Proteomic Analysis of Plasminogen Receptors
纤溶酶原受体的蛋白质组学分析
基本信息
- 批准号:7589725
- 负责人:
- 金额:$ 47.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-04-06 至 2012-03-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAddressArterial Fatty StreakAtherosclerosisBindingBinding ProteinsBinding SitesCell surfaceCellsDataDevelopmentExtracellular Matrix DegradationGoalsIn VitroInfiltrationInflammationInflammatoryInflammatory ResponseLaboratoriesMacrophage Colony-Stimulating FactorMolecularNeoplasm MetastasisPathologic ProcessesPathway interactionsPhenotypePhysiologicalPhysiological ProcessesPlasminPlasminogenPlasminogen ActivatorProcessProteomicsRegulationRoleStagingStimulusSurfaceTestingTumor Cell InvasionUp-RegulationWound Healingbasecell motilityin vivoinsightmacrophagemonocyteplasminogen receptorreceptorreceptor expressionreceptor functionresponsetissue processing
项目摘要
DESCRIPTION (provided by applicant): The assembly of plasminogen and plasminogen activators on cell surfaces is a crucial control point for positive regulation of cell surface proteolytic activity necessary in both physiological and pathological processes requiring cell migration. The long-term goal of our laboratory is to understand the mechanisms by which plasminogen binding to cells is regulated, in order to function in physiological and pathological processes. This proposal is based on data demonstrating that up-regulation of plasminogen binding function occurs during differentiation of viable monocytes into viable macrophages. In preliminary studies, we identified three major candidate plasminogen receptors up-regulated in response to M-CSF that have not been recognized previously as plasminogen binding sites on monocytes. The objective of this application is to elucidate the role of M-CSF-up-regulated plasminogen receptors in monocyte/macrophage recruitment. The central hypothesis to be addressed is that plasminogen receptors are up-regulated during monocyte/macrophage maturation and facilitate recruitment of these cells in response to inflammatory stimuli, by promoting plasminogen activation and localizing the proteolytic activity of plasmin on the cell surface. To test this hypothesis we will I) identify the major pro- fibrinolytic plasminogen binding proteins on M-CSF-stimulated cells and quantify their expression during monocyte development in vivo and II) test the hypothesis that M-CSF-up-regulated plasminogen receptors promote plasminogen activation, extracellular matrix degradation and cell migration in vitro and in vivo. We expect that accomplishment of our specific aims will provide fundamental insights that will apply to the regulation of inflammation. Furthermore, because monocyte/macrophage recruitment and infiltration is a key feature of the atherosclerotic lesion, our results should apply to the understanding of atherosclerosis.
描述(由申请人提供):纤溶酶原和纤溶酶原激活剂在细胞表面的组装是细胞表面蛋白水解活性正调节的关键控制点,该活性在需要细胞迁移的生理和病理过程中是必需的。我们实验室的长期目标是了解纤溶酶原与细胞结合的调节机制,以便在生理和病理过程中发挥作用。该提议基于的数据表明,纤溶酶原结合功能的上调发生在活单核细胞分化为活巨噬细胞的过程中。在初步研究中,我们鉴定了三种主要的候选纤溶酶原受体,它们响应 M-CSF 而上调,这些受体以前未被识别为单核细胞上的纤溶酶原结合位点。本申请的目的是阐明 M-CSF 上调的纤溶酶原受体在单核细胞/巨噬细胞募集中的作用。要解决的中心假设是,纤溶酶原受体在单核细胞/巨噬细胞成熟过程中上调,并通过促进纤溶酶原激活并将纤溶酶的蛋白水解活性定位在细胞表面,促进这些细胞响应炎症刺激而募集。为了检验这一假设,我们将 I) 鉴定 M-CSF 刺激的细胞上主要的纤溶酶原结合蛋白,并量化它们在体内单核细胞发育过程中的表达,II) 检验 M-CSF 上调的纤溶酶原受体促进纤溶酶原激活、细胞外基质降解和细胞体外和体内迁移。我们期望我们特定目标的实现将为炎症的调节提供基本的见解。此外,由于单核细胞/巨噬细胞的募集和浸润是动脉粥样硬化病变的关键特征,因此我们的结果应适用于对动脉粥样硬化的理解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lindsey A Miles其他文献
Lindsey A Miles的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lindsey A Miles', 18)}}的其他基金
Distinguishing plasminogen-dependent and plasminogen-independent roles of the plasminogen receptor, Plg-RKT
区分纤溶酶原受体 Plg-RKT 的纤溶酶原依赖性和纤溶酶原非依赖性作用
- 批准号:
10219891 - 财政年份:2020
- 资助金额:
$ 47.38万 - 项目类别:
A Novel Plasminogen Receptor Promotes Adipose Function and Metabolic Homeostasis
新型纤溶酶原受体促进脂肪功能和代谢稳态
- 批准号:
9918949 - 财政年份:2019
- 资助金额:
$ 47.38万 - 项目类别:
A Novel Plasminogen Receptor Promotes Adipose Function and Metabolic Homeostasis
新型纤溶酶原受体促进脂肪功能和代谢稳态
- 批准号:
9765020 - 财政年份:2019
- 资助金额:
$ 47.38万 - 项目类别:
A Novel Plasminogen Receptor Promotes Adipose Function and Metabolic Homeostasis
新型纤溶酶原受体促进脂肪功能和代谢稳态
- 批准号:
10397036 - 财政年份:2019
- 资助金额:
$ 47.38万 - 项目类别:
2016 Plasminogen Activation and Extracellular Proteolysis Gordon Research Conference and Gordon-Kenan Research Seminar
2016年纤溶酶原激活与细胞外蛋白水解戈登研究会议暨戈登-凯南研究研讨会
- 批准号:
8983504 - 财政年份:2015
- 资助金额:
$ 47.38万 - 项目类别:
Regulation of cellular functions by the plasminogen receptor, Plg-RKT
纤溶酶原受体 Plg-RKT 调节细胞功能
- 批准号:
9914115 - 财政年份:2007
- 资助金额:
$ 47.38万 - 项目类别:
Regulation of plasminogen-dependent cell functions by the novel receptor, Plg-RKT
新型受体 Plg-RKT 调节纤溶酶原依赖性细胞功能
- 批准号:
8438378 - 财政年份:2007
- 资助金额:
$ 47.38万 - 项目类别:
相似国自然基金
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Integration of advanced imaging and multiOMICs to elucidate pro-atherogenic effects of endothelial-to-Immune cell-like transition (EndICLT)
整合先进成像和多组学技术来阐明内皮细胞向免疫细胞样转变的促动脉粥样硬化效应 (EndICLT)
- 批准号:
10606258 - 财政年份:2023
- 资助金额:
$ 47.38万 - 项目类别:
Targeted drug delivery for the treatment of cardiovascular disease and its clinical complications
靶向给药治疗心血管疾病及其临床并发症
- 批准号:
10371510 - 财政年份:2022
- 资助金额:
$ 47.38万 - 项目类别:
Targeted drug delivery for the treatment of cardiovascular disease and its clinical complications
靶向给药治疗心血管疾病及其临床并发症
- 批准号:
10545093 - 财政年份:2022
- 资助金额:
$ 47.38万 - 项目类别:
Role of Platelet Bruton's Tyrosine Kinase (BTK) in Atherosclerosis
血小板布鲁顿酪氨酸激酶 (BTK) 在动脉粥样硬化中的作用
- 批准号:
10549282 - 财政年份:2021
- 资助金额:
$ 47.38万 - 项目类别:
Kruppel-like factor 11 (KLF11) and atherosclerosis
Kruppel 样因子 11 (KLF11) 和动脉粥样硬化
- 批准号:
9924279 - 财政年份:2017
- 资助金额:
$ 47.38万 - 项目类别: